Summit Securities Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-278
| Closed | -$6.08K | – | 940 |
|
|
2025
Q1 | $6.08K | Buy |
+278
| New | +$6.08K | ﹤0.01% | 462 |
|
|
2024
Q4 | – | Sell |
-248
| Closed | -$7K | – | 502 |
|
|
2024
Q3 | $7K | Buy |
+248
| New | +$7K | ﹤0.01% | 292 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 314 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 456 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 402 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 900 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 697 |
|